KR101154501B1 - A composition of eliminating keratin comprising saussurea involucratae extract - Google Patents
A composition of eliminating keratin comprising saussurea involucratae extract Download PDFInfo
- Publication number
- KR101154501B1 KR101154501B1 KR1020050134150A KR20050134150A KR101154501B1 KR 101154501 B1 KR101154501 B1 KR 101154501B1 KR 1020050134150 A KR1020050134150 A KR 1020050134150A KR 20050134150 A KR20050134150 A KR 20050134150A KR 101154501 B1 KR101154501 B1 KR 101154501B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- composition
- skin
- cheonsan
- exfoliation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000284 extract Substances 0.000 title claims abstract description 46
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- 102000011782 Keratins Human genes 0.000 title description 6
- 108010076876 Keratins Proteins 0.000 title description 6
- 241000133134 Saussurea Species 0.000 title description 3
- 238000004299 exfoliation Methods 0.000 claims abstract description 30
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 239000002537 cosmetic Substances 0.000 claims description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000006071 cream Substances 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 6
- 239000001993 wax Substances 0.000 claims description 6
- 239000000686 essence Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 239000002674 ointment Substances 0.000 claims description 5
- -1 fatty acid esters Chemical class 0.000 claims description 4
- 238000009472 formulation Methods 0.000 claims description 4
- 239000008213 purified water Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims 2
- 229930195729 fatty acid Natural products 0.000 claims 2
- 239000000194 fatty acid Substances 0.000 claims 2
- 150000001298 alcohols Chemical class 0.000 claims 1
- 150000004665 fatty acids Chemical class 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 239000012188 paraffin wax Substances 0.000 claims 1
- 208000002193 Pain Diseases 0.000 abstract description 10
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 abstract description 7
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 abstract description 7
- 229930016911 cinnamic acid Natural products 0.000 abstract description 7
- 235000013985 cinnamic acid Nutrition 0.000 abstract description 7
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 abstract description 7
- 239000004094 surface-active agent Substances 0.000 abstract description 5
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 30
- 210000003491 skin Anatomy 0.000 description 26
- 210000000434 stratum corneum Anatomy 0.000 description 17
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 10
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- 229940120503 dihydroxyacetone Drugs 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000004310 lactic acid Substances 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 229940061720 alpha hydroxy acid Drugs 0.000 description 4
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 4
- 210000002510 keratinocyte Anatomy 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 210000001047 desmosome Anatomy 0.000 description 3
- 210000001339 epidermal cell Anatomy 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000007306 turnover Effects 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 229940113124 polysorbate 60 Drugs 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000013517 stratification Methods 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 241000229722 Perilla <angiosperm> Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 229960001777 castor oil Drugs 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229940113116 polyethylene glycol 1000 Drugs 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- ALDITMKAAPLVJK-UHFFFAOYSA-N prop-1-ene;hydrate Chemical group O.CC=C ALDITMKAAPLVJK-UHFFFAOYSA-N 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037075 skin appearance Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Medical Informatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Alternative & Traditional Medicine (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 천산설연 추출물을 포함하는 각질제거용 조성물에 관한 것으로, 보다 상세하게는 전체 조성물에 대하여 천산설연 추출물을 0.1 내지 10 중량%로 포함하며, 왁스 및 계면활성제를 더욱 포함하는 각질제거용 조성물에 대한 것이다.The present invention relates to a exfoliating composition comprising cinnamic acid extract, more specifically 0.1 to 10% by weight of cinnamic acid extract based on the total composition, an exfoliating composition further comprising a wax and a surfactant It is about.
본 발명의 각질제거용 조성물은 피부 따가움은 적고, 각질 박리 촉진 효과가 우수한 특징을 갖는다.Exfoliation composition of the present invention has a feature of less skin stinging, excellent exfoliation promoting effect.
Description
[산업상 이용분야][Industrial use]
본 발명은 천산설연 추출물을 포함하는 각질제거용 조성물에 관한 것으로서, 보다 상세하게는 천산설연 추출물 0.1 내지 10 중량%를 포함하므로써 자극이 적고 각질제거 효과가 뛰어난 각질제거용 조성물에 관한 것이다.The present invention relates to a composition for exfoliation comprising cheonsan seolyeon extract, and more particularly to a composition for exfoliation having less irritation and excellent exfoliation effect by containing 0.1 to 10% by weight of cheonsan sulyeon extract.
[종래기술] [Private Technology]
일반적으로 피부는 피부상층부터 표피, 진피, 피하지방층의 세 부분으로 분류된다. 이중 표피는 다시 각질층, 과립층, 유극층, 기저층으로 세분되며, 기저층의 표피세포는 피부상부로 올라오면서 분화되어, 최종적으로는 각질층에 도달하게 된다. 각질층에 도달한 표피세포는 핵이 소실되고 케라틴이라고 불리는 불수용성 단백질로 채워지면서 죽은 세포로 전환된다. Generally, the skin is classified into three parts: the upper skin layer, the epidermis, the dermis, and the subcutaneous fat layer. The epidermis is subdivided into stratum corneum, granule layer, pore layer, and basal layer. The epidermal cells of basal layer are differentiated as they rise up the skin and finally reach the stratum corneum. The epidermal cells that reach the stratum corneum lose their nuclei and are converted to dead cells as they are filled with insoluble proteins called keratin.
각질층은 분화된 표피세포(각질세포)와 이들 사이를 채워주는 피부지질(skin lipid)로 구성되며 체내 물질이 외부로 나가는 것을 막아주고 외부의 물리적, 화학적, 생물학적 자극으로부터 인체를 보호하는 방어기능을 한다. 각질세포는 데스모 좀이라 불리는 단백질에 의하여 연결되어 있으며, 각질층 상부로 올라갈수록 데스모좀은 분해되어 각질세포간 응집력이 약화되고, 최종적으로 각질세포는 피부로부터 분리되어 떨어져 나간다. 정상피부의 경우 각질층은 15 내지 20 층으로 구성되고, 이들이 완전히 분리되는데 15 내지 20일이 소요(British J. of Dermatology, 86, 14-19, 1974; K.M.Halprin, 향장회지, 12(4), 265-271, 1988;M. Takahashi)되므로 하루에 약 1층의 각질세포층이 떨어져 나간다. The stratum corneum consists of differentiated epidermal cells (skin cells) and the skin lipids that fill them in. The stratum corneum prevents the release of substances in the body and protects the body from external physical, chemical and biological stimuli. do. Keratinocytes are connected by a protein called desmosomes, and as they rise up the stratum corneum, the desmosomes break down, weakening cohesion between keratinocytes, and finally keratinocytes separate from the skin and fall off. In normal skin, the stratum corneum consists of 15 to 20 layers, and it takes 15 to 20 days for them to be completely separated (British J. of Dermatology, 86, 14-19, 1974; KMHalprin, Perilla, 12 (4), 265-271, 1988; M. Takahashi), so about one layer of keratinocytes per day falls off.
노화피부, 건조피부, 여드름피부 등은 각질층의 분리가 정상보다 늦어져 각질층이 두꺼워지는(각질중층화) 현상을 보이며, 피부 외관상으로 나타나는 두드러진 특징은 피부비늘(scale)의 발생이다. 각질중층화는 주로 피부의 보습력 감소, 데스모좀 분해효소의 생성 및 활성 감소, 세포활성 저하 등에 기인하며 피부노화, 자외선 노출, 공해 등이 유발요인이 된다. 이러한 내외적인 요인에 의하여 두꺼워진 각질층을 외부에서 인위적으로 얇게 해주면 각질층 밑에 있는 살아있는 세포의 활성 혹은 재생이 증가되어 피부외관에 나타나는 피부비늘이 감소하고, 피부가 부드러워지는 효과가 있어 자극이 유발되지 않는 범위 내에서 각질중층화를 해소하려는 연구가 많이 진행되고 있다. Aging skin, dry skin, acne skin and the like, the separation of the stratum corneum is slower than normal, the stratum corneum thickening (stratum corneum) phenomenon, the outstanding feature that appears in the appearance of the skin is the scale of the skin (scale). The stratum corneum stratification is mainly due to decreased skin moisturizing power, decreased production and activity of desmosome degrading enzymes, decreased cellular activity, and causes skin aging, UV exposure, and pollution. Artificially thinning the thickened stratum corneum by these internal and external factors increases the activity or regeneration of living cells under the stratum corneum, reducing skin scales appearing on the skin appearance and softening the skin, which does not cause irritation. There is a lot of research to solve the keratin stratification within the scope.
각질중층화를 해소하기 위하여는 피부를 물리적으로 문지르거나 화학적 박피술을 이용하는데, 특히 화학적 박피는 잔주름개선, 거친 피부 완화, 잡티제거 등의 부가적인 효과가 있다. 이러한 화학적 박피에 이용되는 알파하이드록시산의 농도는 적어도 20 내지 30% 이상의 고농도가 이용되나, 10%미만의 저농도에서는 각질층을 서서히 박리시키고(J. Am. Acad. Dermatol., 11, 867-879, 1984;Van Scott등), 피부보습증진(happi, july, 66-68, 1994;Tom 등), 잔주름완화(Cutis, 43, 222-228, 1989; Van Scott등) 등의 효과도 보여 최근 화장품이나 제약업계에서 많은 제품들이 출시되고 있다. 그러나 알파하이드록시산은 낮은 pH로 인하여 따가움을 호소하며 자극이 유발되는 단점도 있어, 사용농도와 pH조절이 피부부작용을 완화하는데 매우 중요하다. In order to eliminate the stratum corneum, the skin is physically rubbed or chemical dermabrasion is used. In particular, chemical dermabrasion has the additional effects such as fine wrinkle improvement, rough skin relief, and blemish removal. The concentration of the alpha hydroxy acid used for such chemical peeling is used at a high concentration of at least 20 to 30% or more, but at a low concentration of less than 10%, the stratum corneum is slowly peeled off (J. Am. Acad. Dermatol., 11, 867-879). , 1984; Van Scott et al.), Skin moisturization (happi, july, 66-68, 1994; Tom et al.), And fine lines (Cutis, 43, 222-228, 1989; Van Scott et al.). Many products are released in the pharmaceutical industry. However, alpha hydroxy acid complains of tingling and irritation due to low pH, so use concentration and pH control are very important to alleviate skin side effects.
또한, 알파하이드록시산에 단백질, 지질 등을 붙이거나 부작용완화제의 첨가, 구조 변경 등을 시도하여 피부부작용을 감소시킬 수 있으나, 각질박리, 잔주름개선 등의 효과 역시 감소되어 최소의 부작용과 최대의 효과를 얻기에는 아직 어려운 실정이다.In addition, the skin side effects can be reduced by attaching proteins, lipids, etc. to the alpha hydroxy acid, or by adding side effect relieving agents or modifying the structure, but the effects such as exfoliation and fine wrinkle improvement are also reduced, thereby minimizing side effects and maximum It is still difficult to get the effect.
천산설연(Saussurea involucrates)은 중국에서 주로 생장하는 식물로, 이에 대하여 알려진 약리작용으로는 항암, 항염, 심혈관계통에 효능이 있으며, 천산설연에 대한 특허로는 피부유연효과, 보습증진, 피부탄력효과를 주장한 발명(중국 특허출원공개번호 제106286호), 보습, 자외선 차단효과를 주장한 발명(중국 특허출원공개번호 제1513437호), 피부영양공급, 보습효과를 주장한 발명(중국 특허출원공개번호 제1497423호) 등이 있다.Cheonsan Seolyeon (Saussurea involucrates) is a plant that grows mainly in China, and its pharmacological effects are known to be effective in anti-cancer, anti-inflammatory, and cardiovascular system. Patents in Cheonsan Seolyeon have skin softening effect, moisturizing effect and skin elasticity effect. Invention (China Patent Application Publication No. 106286) insisting on the invention, Invention insisting on the moisturizing and UV protection effect (China Patent Application Publication No. 1513437), Invention claiming the skin nutrition supply, moisturizing effect (China Patent Application Publication No. 1497423 Ho).
본 발명은 상기와 같은 문제점을 해결하기 위한 것으로서, 본 발명의 목적은 각질박리 효과가 뛰어나고 따가움 증상이 적은 천산설연 추출물을 포함하는 각질제거용 조성물을 제공하는 것이다. The present invention is to solve the above problems, an object of the present invention is to provide an exfoliation composition comprising a cheonsan sulyeon extract with excellent exfoliation effect and less stinging symptoms.
본 발명은 상기 목적을 달성하기 위하여, 천산설연 추출물 0.1 내지 10 중량%를 포함하는 각질제거용 조성물을 제공한다.The present invention provides a composition for exfoliation comprising 0.1 to 10% by weight of cheonsan seolyeon extract to achieve the above object.
이하, 본 발명을 보다 상세하게 설명한다. Hereinafter, the present invention will be described in more detail.
천산설연(Saussurea involucrates)는 중국 신강위글족, 내몽골족들이 약재로 사용하였으며, 종자는 0℃에서 발아하고, 3 내지 5℃에서 생장하며, 새싹은 영하 21℃에서 견딜 수 있는 식물이다. 이는 생장기가 2개월도 안되는 환경하에서도 기타 식물의 5 내지 7배 이상 높게 자라며, 꽃은 5년이 되어야 피지만, 실제 생장기간은 8개월에 지나지 아니하여 생물학에서 비교적 독특하게 취급된다. 이러한 천산설연은 주로 중국의 서장, 운남, 신강, 청해, 감숙 사천 등에 분포하며, 고한지역의 해발 4000m 전후의 높은 산 지역이나 사막, 암석틈새에서 생장한다.Cheonsan Seolyeon (Saussurea involucrates) was used by the Chinese Xinjiang Wiggle and Inner Mongolia as a medicinal herb, the seeds germinate at 0 ° C, grow at 3 to 5 ° C, and the shoots can withstand temperatures below minus 21 ° C. It grows more than five to seven times higher than other plants even in an environment of less than two months in growth, and flowers bloom only after five years, but the actual growth period is only eight months, which is relatively unique in biology. The Tianshan Snow Lime is mainly distributed in Xinjiang, Yunnan, Xinjiang, Qinghai and Gansu Sichuan, and grows in high mountain areas, deserts and rock crevices around 4000m above sea level.
본 발명자는 상기 천산설연의 알려진 효능 이외에도 각질박리 효과가 있음에 착안하여 본 발명의 각질제거용 조성물을 발명하게 되었다.The inventors of the present invention have invented the exfoliating composition of the present invention by paying attention to the exfoliation effect in addition to the known effects of Chunshan Sulyeon.
본 발명의 각질제거용 조성물은 천산설연 추출물을 0.1 내지 10 중량%로 포함할 수 있으며, 왁스 및 계면활성제를 더욱 포함할 수 있다. 바람직하게는 상기 천산설연 추출물은 전체 조성물의 건조 중량에 대하여 0.1 내지 5 중량%로 포함할 수 있다. 0.1 중량% 미만인 경우에는 실질적인 각질박리효과를 기대하기 어렵고, 10 중량%를 초과하는 경우에는 제형의 안정성에 영향을 미치며, 효과가 중량%의 증가에 비례하여 좋아지지 아니한다.Exfoliating composition of the present invention may comprise 0.1 to 10% by weight of cheonsan sulyeon extract, it may further comprise a wax and a surfactant. Preferably the cheonsan seolyeon extract may comprise 0.1 to 5% by weight relative to the dry weight of the total composition. If it is less than 0.1% by weight it is difficult to expect a substantial exfoliation effect, if it exceeds 10% by weight affects the stability of the formulation, the effect does not improve in proportion to the increase in weight%.
본 발명에서 제공하는 천산설연은 잎, 꽃, 줄기 또는 뿌리 등 추출부위는 어느 부위로 한정하지 아니하며, 통상의 추출 방법에 의하여 추출할 수 있다. 또한, 추출용매의 종류 및 함량 등도 목적에 따라 임의 선정하여 사용할 수 있다. 바람직하게는, 상기 추출용매는 정제수, 탄소수 1 내지 4인 무수 또는 함수 메탄올, 에탄올, 프로필알코올, 부틸알코올, 에틸아세테이트, 글리세린, 프로필렌글리콜 및 부틸렌글리콜을 포함한 용매군 중에서 선택된 하나의 순수용매 또는 둘 이상이 조합된 혼합용매이며, 생약의 전체 부피에 대하여 1 내지 20배의 양으로 사용할 수 있다.The cheonsan sulyeon provided by the present invention is not limited to any site, such as leaves, flowers, stems or roots, it can be extracted by a conventional extraction method. In addition, the type and content of the extraction solvent may be arbitrarily selected according to the purpose. Preferably, the extractant is one pure solvent selected from a solvent group including purified water, anhydrous or hydrous methanol having 1 to 4 carbon atoms, ethanol, propyl alcohol, butyl alcohol, ethyl acetate, glycerin, propylene glycol and butylene glycol, or Two or more are mixed solvents combined and may be used in an amount of 1 to 20 times the total volume of the herbal medicine.
상기 본 발명의 각질제거용 조성물은 왁스 성분 또는 계면활성제를 더욱 포함할 수 있다. 상기 왁스 성분은 유화를 안정하게 해주는 성분으로서, 세틸알콜, 스테아릴알콜 및 베헤닐알콜 등의 다가 알코올류나, 비스왁스, 쉐어버터로 이루어지는 군으로부터 선택된 1종 이상의 혼합물일 수 있다.The exfoliation composition of the present invention may further comprise a wax component or a surfactant. The wax component is a component that stabilizes emulsification, and may be one or more mixtures selected from the group consisting of polyhydric alcohols such as cetyl alcohol, stearyl alcohol, and behenyl alcohol, bis wax, and shea butter.
또한, 상기 계면활성제는 폴리옥시에틸렌 경화피마자유, 폴리소르베이트 60, 폴리소르베이트 20, 모노스테아린산 소르비탄, 폴리소르베이트 80 및 글리세릴스테아레이트/라우레스-23 로 이루어지는 군으로부터 선택된 1종 이상의 것일 수 있으며, 음이온성 계면활성제, 양이온성 계면활성제 또는 비이온성 계면활성제 모두를 이용할 수 있다.In addition, the surfactant is at least one selected from the group consisting of polyoxyethylene cured castor oil, polysorbate 60, polysorbate 20, sorbitan monostearate, polysorbate 80, and glyceryl stearate / laures-23 And anionic surfactants, cationic surfactants or nonionic surfactants can be used.
다만, 본 발명의 각질제거용 조성물은 상기 예에 한정되지 아니하고 통상적으로 화장품에 사용할 수 있는 모든 왁스 또는 계면활성제를 포함할 수 있다.However, the exfoliating composition of the present invention is not limited to the above examples and may include all waxes or surfactants that can be commonly used in cosmetics.
또한, 본 발명의 조성물은 통상의 화장품에 사용가능한 모든 종류의 성분, 예컨대 자외선 차단제, 향료, 방부제, 산화방지제, 색소 등을 사용할 수 있으며, 이를 첨가함으로써 유연화장수, 영양화장수, 영양크림, 맛사지크림, 에센스, 팩 등 을 포함한 화장료, 비누, 폼클렌징, 바디클린저, 샴푸, 린스 등을 포함하는 피부 또는 모발세정제 및 피부외용연고의 제형을 가질 수 있다.In addition, the composition of the present invention can be used for all kinds of ingredients that can be used in conventional cosmetics, such as sunscreen, fragrances, preservatives, antioxidants, pigments, etc., by adding it softening cosmetics, nourishing cosmetics, nutrition cream, massage cream It may have a formulation of skin or hair cleanser and external skin ointment, including cosmetics, soaps, foam cleansing, body cleansers, shampoos, rinses, etc., including essences, packs and the like.
이하, 본 발명의 바람직한 실시예를 기재한다. 다만, 하기의 실시예는 본 발명의 바람직한 일 실시예일 뿐, 본 발명이 하기 실시예에 의해 한정되는 것은 아니다.Hereinafter, preferred embodiments of the present invention will be described. However, the following examples are only preferred embodiments of the present invention, and the present invention is not limited to the following examples.
실시예Example 1 내지 11: 1 to 11: 천산설연Cheonsan Snowyeon 추출물의 제조 Preparation of Extract
일차적으로 천산설연을 완전 건조한 후, 추출 용매로서 증류수, 에탄올, 메탄올, 부탄올, 에틸아세테이트, 프로판올, 글리세린, 함수 부틸렌글리콜, 함수 프로필렌글리콜로 구성된 그룹으로부터 하기 표 1에 나타낸 실시예와 같이 선택된 하나 이상의 용매를 천산설연 건조물에 대하여 10~20배 부피량으로 가하였다. 추출 방법으로는 선택된 용매에 준비된 생약성분을 넣고 냉각 콘덴서가 달린 추출기에서 12시간 끓여서 추출한 후 300메쉬 여과포로 여과하고, 상기 여과액을 4 내지 15℃에서 7일간 방치하여 숙성시킨 후, 와트만 여과지로 여과함으로써 천산설연 추출물을 제조하였다.First, after completely drying the cheonsanolyeon, one selected from the group consisting of distilled water, ethanol, methanol, butanol, ethyl acetate, propanol, glycerin, hydrous butylene glycol, hydrous propylene glycol as an extraction solvent as shown in Table 1 below The above solvent was added at a volume of 10 to 20 times the amount of dry lead of Chunsan. Extraction method, the prepared herbal ingredients in the selected solvent, boiled for 12 hours in an extractor equipped with a cooling condenser and extracted with 300 mesh filter cloth, the filtrate was left at 4 to 15 ℃ for 7 days to mature, and then Whatman filter paper By filtering with cheonseolyeon extract was prepared.
실시예Example 12: 12: 천산설연Cheonsan Snowyeon 추출물을 포함하는 Containing extract 피부외용연고Skin Ointment
하기 표 2의 조성에 따른 성분을 가열하여 완전히 용해한 후, 4500rpm 으로 교반하여 유화한 뒤, 냉각하여 50℃ 가 되면 다시 천산설연 추출물을 첨가하여 3분간 교반한 후, 실온까지 냉각하여 실시예 2의 천산설연 추출물을 포함하는 피부외용연고를 제조하였다.After heating and completely dissolving the components according to the composition of Table 2, and then stirred at 4500rpm to emulsify, and then cooled to 50 ℃ again to add the cheonsansulyeon extract and stirred for 3 minutes, then cooled to room temperature of Example 2 An external skin ointment containing cheonsan seolyeon extract was prepared.
실시예Example 13: 13: 천산설연Cheonsan Snowyeon 추출물을 포함하는 에센스 Essence Containing Extract
하기 표 3의 조성에 따른 성분을 가열하여 완전히 용해한 후, 호모믹서로 교반하면서 5분간 유화한 뒤, 냉각하여 50℃가 되면 다시 실시예 2의 천산설연 추출물 5g을 첨가하여 3 분간 교반한 후, 실온까지 냉각하여 실시예 2의 천산설연 추출물을 포함하는 에센스를 제조하였다.After heating and completely dissolving the components according to the composition of Table 3, after emulsifying with a homomixer for 5 minutes while stirring, and when cooled to 50 ℃ again after adding 5 g of cheonsansulfyeon extract of Example 2 and stirring for 3 minutes, Cooling to room temperature to prepare an essence containing the cheonsansulyeon extract of Example 2.
실시예Example 14: 14: 천산설연Cheonsan Snowyeon 추출물을 포함하는 영양크림 Nutritional Cream Containing Extract
하기 표 4의 조성에 따른 성분을 가열하여 완전히 용해한 후, 호모믹서로 교반하면서 5분간 유화한 뒤, 냉각하여 50℃가 되면 다시 실시예 2의 천산설연 추출물 5g을 첨가하여 3 분간 교반한뒤, 실온까지 냉각하여 실시예 2의 천산설연 추출물을 포함하는 영양크림을 제조하였다.After heating the components according to the composition of Table 4 to completely dissolve, after emulsifying with a homomixer for 5 minutes while stirring, and when cooled to 50 ℃ again after adding 5g of cheonsansulyeon extract of Example 2 and stirring for 3 minutes, Cooling to room temperature to prepare a nourishing cream containing the extract of Cheonsan Sulyeon of Example 2.
실험예Experimental Example 1: One: 천산설연Cheonsan Snowyeon 추출물의 Extract 각질박리Exfoliation 촉진 효과 Promotion effect
피시험자로 20 내지 40세 사이의 건강한 남성 30명을 선별하여 실시예 2에서 얻어진 추출물을 도포하기 전, 피시험자의 팔 상박부 안쪽 색상을 Chroma meter(CR-200, Minolta, 일본)로 측정한 후 10% Dihydroxy acetone(DHA)을 Hill top chamber The Hill Top Companies)에 0.4㎖ 가량 넣고 팔 상박부 안쪽에 6시간 동안 부착하였다. 24시간 경과 후 DHA에 의해 갈색으로 착색된 부위의 색상을 측정하여 시료 도포전과의 색상차이를 비교하였다. 이후 1일 2회씩 시료를 도포하면서 매일 탈색되는 정도를 Chroma meter로 측정하여 원래의 피부색으로 돌아오는데 걸리는 시간을 측정하였다. 각질 박리율은 아래의 식으로 계산하여 하기 표 5에 나타냈다.Thirty healthy males between the ages of 20 and 40 years were selected as subjects, and the inner color of the upper arm region of the subject was measured with a Chroma meter (CR-200, Minolta, Japan) before applying the extract obtained in Example 2. 10% Dihydroxy acetone (DHA) was added to the Hill top chamber The Hill Top Companies) about 0.4ml and attached to the inner arm upper arm for 6 hours. After 24 hours, the color of the brown-colored part was measured by DHA, and the color difference was compared with that before application of the sample. Thereafter, while applying the sample twice a day, the degree of discoloration was measured by a chroma meter every day, and the time taken to return to the original skin color was measured. Keratin peeling rate was calculated by the following formula and shown in Table 5.
각질박리율(%) = (Blank의 TT - 시료도포시 TT)/ Blank의 TT x 100Exfoliation rate (%) = (Blank TT-TT during sample application) / Blank TT x 100
TT (Turnover Time): 기존의 각질층이 새로운 각질층으로 대체되는데 걸리는 시간으로서, 본 실험에서는 DHA에 의해 착색된 피부가 완전히 원상 복귀 되는데 걸리는 시간. TT (Turnover Time): The time taken for the old stratum corneum to be replaced by the new stratum corneum. In this experiment, the time taken for the skin to be colored by DHA to fully revert.
Blank* : DHA로 착색한 후, 아무 시료도 바르지 않은 군Blank * : No sample applied after staining with DHA
SCL** (simple cosmetic liquid): 피부에 도포성을 높이기 위하여 사용되는 용매(물:에탄올:1,3-butylene glycol=80:15:5)를 말하며, 본 각질박리 실험에 사용되는 모든 시료는 SCL에 용해시켜 사용함.SCL ** (simple cosmetic liquid): refers to a solvent (water: ethanol: 1,3-butylene glycol = 80: 15: 5) used to improve applicability to skin. All samples used in this exfoliation experiment are Used by dissolving in SCL.
상기 표 5 에서 알 수 있듯이, 일반적으로 우수한 각질박리제로 알려진 글리콜릭산(Glycolic acid) 및 젖산(Lactic acid)은 5% 농도 사용시 약 20% 정도의 각질박리효과를 보인 반면, 같은 농도의 천산설연 추출물은 상기 두 알파하이드록시산에 비하여 약 2배에 가까운 40.2% 의 각질박리 효과를 보였다.As can be seen in Table 5, glycolic acid and lactic acid, which are generally known as excellent exfoliants, showed about 20% exfoliation effect when used at 5% concentration, while the same concentration of cinnamic acid extract was used. Showed an exfoliation effect of about 40.2%, which is nearly twice that of the two alpha hydroxy acids.
또한, 천산설연 추출물의 농도에 따른 각질박리 효과를 알아보기 위하여 하기 농도로 천산설연 추출물을 희석하여 상기의 방법으로 각질박리 효과를 측정하여 표 6에 나타냈다.In addition, in order to determine the exfoliation effect according to the concentration of cinnamic acid snow extract, dilute the cinnamic acid extract to the following concentration and measure the exfoliation effect by the above method is shown in Table 6.
상기 표 6에서 알 수 있듯이, 천산설연 추출물의 농도가 0.1% 미만인 경우에는 10% 미만의 미미한 각질박리 효과를 보였으며, 천산설연 추출물의 농도가 10%인 경우에는 약 50%에 가까운 각질박리 효과를 보였으므로, 본 발명의 천산설연 추출물을 포함하는 각질박리제는 0.1 내지 10% 농도의 천산설연 추출물을 포함하는 것이 바람직할 것으로 보인다.As can be seen in Table 6, when the concentration of the cheonsan sulyeon extract is less than 0.1% showed less than 10% of the exfoliation effect, when the concentration of the cheonsan sulyeon extract is about 10% keratin exfoliation effect Since the keratin release agent containing the cheonsan sulyeon extract of the present invention seems to include a cheonsan sulyeon extract of 0.1 to 10% concentration.
실험예Experimental Example 2: 2: 천산설연Cheonsan Snowyeon 추출물의 따가움 정도의 측정 Determination of Stinginess of Extracts
실험예 1에서 각질박리 효과가 현저히 우수한 것으로 밝혀진 5% 농도의 실시예 2 의 천산설연 추출물 400uL를 이용하여 동일한 농도 및 양의 글리콜릭산 및 젖산과 함께 다음과 같이 피부 따가움 유발정도(stinging test)를 측정하였다.Using the 5% concentration 400uL Cheonsan Sulyeon extract of Example 2, which was found to be remarkably excellent in exfoliation effect in Experimental Example 1 with the same concentration and amount of glycolic acid and lactic acid as described below stinging test (stinging test) Measured.
20 내지 35세 사이의 건강한 여성 30명을 피시험자로 하여 먼저 세안을 하여 기존에 분비된 피지 및 먼지 등을 제거한 후, 항온항습실(27℃, 70% 상대습도)에서 15분간 적응시켰다. 그 후, 부직포에 시료를 0.4㎖ 가량 적시고 코주변 및 뺨에 직경 4cm 크기의 부직포를 붙인 후 20초가 경과된 뒤 이를 제거하였다. 그 후, 하기 표 7의 시간이 경과된 후 아래의 기준에 의하여 피시험자의 주관적 판정으로 따가움 정도를 측정하였다.Thirty healthy women aged between 20 and 35 years old were first rinsed to remove sebum and dust secreted beforehand, and then adapted for 15 minutes in a constant temperature and humidity room (27 ° C., 70% relative humidity). Thereafter, the sample was wetted with about 0.4 ml of the nonwoven fabric, and a nonwoven fabric having a diameter of 4 cm was attached to the periphery of the nose and the cheek, and then removed after 20 seconds. Thereafter, after the time of Table 7 elapsed, the degree of tingling was measured by subjective judgment of the test subject based on the following criteria.
Water
0.13
0.13
Glycolic acid 5%
2.08
Lactic acid 5%
1.95
Cheonsan Snowyeon 5%
0.25
상기 표 8와 같이, 천산설연 추출물을 포함하는 경우 같은 농도의 글리콜릭산 및 젖산에 비하여 따가움 정도가 낮은 것으로 나타났다.As shown in Table 8, it was found that the degree of stinging was lower than that of glycolic acid and lactic acid at the same concentration when the cheonsan seolyeon extract was included.
실험예Experimental Example 3: 3: 실시예Example 12 내지 14의 12 to 14 각질박리Exfoliation 및 따가움 효과 And stinging effect
실시예 12 내지 14의 천산설연 추출물을 포함하는 피부외용연고, 에센스 및 영양크림 각각 400uL 를 이용하여 실험예 1 및 2에서의 방법으로 각질박리율 및 따가움 정도를 측정하여 하기 표 9에 기재하였다.Exfoliation ointment, essence and nourishing cream, each containing the cheonsan seolyeon extracts of Examples 12 to 14 using 400uL each of the exfoliation rate and the degree of tingling by the method in Experimental Examples 1 and 2 are described in Table 9 below.
상기 표 9에서 볼 수 있듯이, 천산설연 추출물이 포함된 본 발명의 실시예 제형들도 모두 높은 각질박리 효과는 물론, 따가움 정도도 매우 낮음을 알 수 있다.As can be seen in Table 9, all of the formulations of the present invention containing the cheonsanolyeon extract can also be seen that not only high exfoliation effect, but also very low degree of stinging.
본 발명의 조성물은 천산설연을 포함하는 각질제거용 화장료 조성물로서, 천산설연을 포함하므로써 기존의 각질제거용 화장료에 비하여 피부 자극이 적을 뿐만 아니라, 뛰어난 각질제거 효과를 갖게 된다.The composition of the present invention is a exfoliating cosmetic composition containing cinnamic acid, and because it contains cinnamic acid, not only has less skin irritation than the existing exfoliating cosmetics, it has an excellent exfoliating effect.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050134150A KR101154501B1 (en) | 2005-12-29 | 2005-12-29 | A composition of eliminating keratin comprising saussurea involucratae extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050134150A KR101154501B1 (en) | 2005-12-29 | 2005-12-29 | A composition of eliminating keratin comprising saussurea involucratae extract |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20070071029A KR20070071029A (en) | 2007-07-04 |
KR101154501B1 true KR101154501B1 (en) | 2012-06-13 |
Family
ID=38506232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020050134150A Expired - Fee Related KR101154501B1 (en) | 2005-12-29 | 2005-12-29 | A composition of eliminating keratin comprising saussurea involucratae extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101154501B1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2673537C2 (en) * | 2017-05-22 | 2018-11-28 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Сибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СибГМУ Минздрава России) | Agent for growth stimulation of granulocyte and lymphoid cells in bone marrow and regeneration of bone tissue and method of its production |
CN111374936A (en) * | 2020-04-02 | 2020-07-07 | 安赛搏(重庆)生物技术有限公司 | Method for preparing saussurea involucrate cell extract by using multi-component liquid system and application thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070031692A (en) * | 2005-09-15 | 2007-03-20 | 현대자동차주식회사 | Incline Mount Engine Cooling Structure of Vehicle |
KR20080031692A (en) * | 2005-06-30 | 2008-04-10 | 마이크로소프트 코포레이션 | Secure instant messaging |
KR20100031692A (en) * | 2007-06-25 | 2010-03-24 | 제너럴 일렉트릭 캄파니 | High intensity discharge lamp with enhanced dimming characteristics |
KR20110031692A (en) * | 2009-09-21 | 2011-03-29 | 윤정희 | Manufacturing method of tip dyed bristles harmless to human body and nontoxic |
-
2005
- 2005-12-29 KR KR1020050134150A patent/KR101154501B1/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080031692A (en) * | 2005-06-30 | 2008-04-10 | 마이크로소프트 코포레이션 | Secure instant messaging |
KR20070031692A (en) * | 2005-09-15 | 2007-03-20 | 현대자동차주식회사 | Incline Mount Engine Cooling Structure of Vehicle |
KR20100031692A (en) * | 2007-06-25 | 2010-03-24 | 제너럴 일렉트릭 캄파니 | High intensity discharge lamp with enhanced dimming characteristics |
KR20110031692A (en) * | 2009-09-21 | 2011-03-29 | 윤정희 | Manufacturing method of tip dyed bristles harmless to human body and nontoxic |
Also Published As
Publication number | Publication date |
---|---|
KR20070071029A (en) | 2007-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102280941B1 (en) | Skin moisturizing and skin soothing cosmetic composition comprising Aloe barbadensis leaf juice and extracts of Pulsatilla koreana, Centella asiatica, Portulaca oleracea and Hamamelis virginiana | |
JP3053368B2 (en) | Cosmetic and method for producing the same | |
KR102236253B1 (en) | Cosmetic composition for skin improvement comprising extracts derived from natural products and method for manufacturing the same | |
KR102576693B1 (en) | Cosmetic composition comprising infused oils of calendular and mixed extracts of plants for moisturizing skin | |
CN110691630A (en) | Use of extract of rambutan peel for moisturizing skin and/or mucous membranes | |
KR100892888B1 (en) | Substances capable of enhancing laminin 5 production in epidermal cells and their use | |
KR101352363B1 (en) | Composition of skin external application for moisturizing comprising Scrophularia buergeriana Miq. extract | |
KR20020040669A (en) | Agents improving skin barrier function | |
KR102058294B1 (en) | Cosmetic composition for skin regenerating containing complex extracts of snail mucus, Boswellia serrata resin and Aloe barbadensis leaf, and cream comprising the same | |
US20040191208A1 (en) | Cosmetic composition for men's skin care and hair care | |
KR101020536B1 (en) | Cosmetic composition for moisturizing skin containing cucumber extract and method for producing same | |
KR102369387B1 (en) | Cosmetic Composition for prevention of depilation or improvement of hair growth | |
KR20110052095A (en) | Cosmetic composition for moisturizing skin containing mushroom extract | |
CN115192501A (en) | Cosmetic composition for skin protection comprising extracts of rice, reed, corn silk, malva sylvestris and aloe vera | |
KR102162377B1 (en) | Extracts derived from natural products and cosmetic composition containing the same, and process for producing the same | |
JP2008184441A (en) | Skin preparation for cell growth promotion | |
KR101922637B1 (en) | Cosmetic composition for skin whitening and improving skin wrinkle comprising horse oil and Rumex acetosella L. extracts | |
KR101154772B1 (en) | Cosmetic composition containing the zizyphus jujuba fruit extract and walnut extract for moisturizing effect on the skin | |
KR101322850B1 (en) | The cosmetic composition for pore-minimizing and inhibition of Sebum Secretion containing the extract of leaves of Mentha arvensis var. piperascens, wheat bud, and Platycodon grandiflorum | |
KR101154501B1 (en) | A composition of eliminating keratin comprising saussurea involucratae extract | |
KR102455132B1 (en) | Cosmetic composition containing lemon myrtle extract and its manufacturing method | |
KR102378103B1 (en) | Cosmetic Composition Comprising Fermented Extract of Morinda citrifolia and Maca Root as Active Ingredient | |
KR102337357B1 (en) | Cosmetic composition for skin regenerating containing Panax Ginseng root extract, Madecassoside, Oenothera Biennis seed oil and Carthamus Tinctorius seed oil | |
KR102759467B1 (en) | Cosmetic Composition Comprising Stem Cell-Conditioned Media, Centella asiatica Leaf Water and Peptides | |
KR102513929B1 (en) | Functional comsmetics materials having composition and composition ratio for skin elasticity, Manufacturing method thereof and Comsmetics for skin care |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20051229 |
|
PG1501 | Laying open of application | ||
A201 | Request for examination | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20091221 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 20051229 Comment text: Patent Application |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20111019 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20120524 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20120601 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20120601 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20160411 Year of fee payment: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20160411 Start annual number: 5 End annual number: 5 |
|
FPAY | Annual fee payment |
Payment date: 20170330 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20170330 Start annual number: 6 End annual number: 6 |
|
FPAY | Annual fee payment |
Payment date: 20190402 Year of fee payment: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20190402 Start annual number: 8 End annual number: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20200504 Start annual number: 9 End annual number: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20210503 Start annual number: 10 End annual number: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20220329 Start annual number: 11 End annual number: 11 |
|
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20250312 |